![]() |
![]() |
Legal status
Patent not validated
(51) | INT.CL. | A61K 49/00 | |
A61K 39/395 | |||
C07K 16/00 | |||
G01N 33/53 |
(11) | Number of the document | 3096798 |
(13) | Kind of document | T |
(96) | European patent application number | 15740774.3 |
Date of filing the European patent application | 2015-01-21 | |
(97) | Date of publication of the European application | 2016-11-30 |
(45) | Date of publication and mention of the grant of the patent | 2020-11-25 |
(46) | Date of publication of the claims translation |
(86) | Number | PCT/US2015/012212 |
Date | 2015-01-21 |
(87) | Number | WO 2015/112578 |
Date | 2015-07-30 |
(30) | Number | Date | Country code |
201461929716 P | 2014-01-21 | US | |
201461944361 P | 2014-02-25 | US | |
201462021397 P | 2014-07-07 | US |
(72) |
CHYUNG, Yung, US
SEXTON, Daniel J., US
TENHOOR, Christopher, US
KENNISTON, Jon A., US
FAUCETTE, Ryan, US
IARROBINO, Ryan, US
BIEDENKAPP, Joseph, US
ADELMAN, Burt, US
|
(73) |
Takeda Pharmaceutical Company Limited ,
1-1, Doshomachi 4-chome
Chuo-ku, Osaka-shi, Osaka,
JP
|
(54) | PLASMA KALLIKREIN BINDING PROTEINS AND USES THEREOF IN TREATING HEREDITARY ANGIOEDEMA |
PLASMA KALLIKREIN BINDING PROTEINS AND USES THEREOF IN TREATING HEREDITARY ANGIOEDEMA |